CDH20
geneOn this page
Also known as CDH7L3Cdh7
Summary
CDH20 (cadherin 20, HGNC:1760) is a protein-coding gene on chromosome 18q21.33, encoding Cadherin-20 (Q9HBT6). Cadherins are calcium-dependent cell adhesion proteins.
This gene is a type II classical cadherin from the cadherin superfamily and one of three cadherin 7-like genes located in a cluster on chromosome 18. The encoded membrane protein is a calcium dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Type II (atypical) cadherins are defined based on their lack of a HAV cell adhesion recognition sequence specific to type I cadherins. Since disturbance of intracellular adhesion is a prerequisite for invasion and metastasis of tumor cells, cadherins are considered prime candidates for tumor suppressor genes.
Source: NCBI Gene 28316 — RefSeq curated summary.
At a glance
- GWAS associations: 5
- Clinical variants (ClinVar): 118 total
- MANE Select transcript:
NM_031891
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:1760 |
| Approved symbol | CDH20 |
| Name | cadherin 20 |
| Location | 18q21.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CDH7L3, Cdh7 |
| Ensembl gene | ENSG00000101542 |
| Ensembl biotype | protein_coding |
| OMIM | 605807 |
| Entrez | 28316 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 retained_intron
ENST00000262717, ENST00000536675, ENST00000538374, ENST00000587582
RefSeq mRNA: 1 — MANE Select: NM_031891
NM_031891
CCDS: CCDS11977
Canonical transcript exons
ENST00000262717 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000669897 | 61499186 | 61499480 |
| ENSE00000807288 | 61502953 | 61503120 |
| ENSE00000807289 | 61507373 | 61507560 |
| ENSE00000807290 | 61527967 | 61528220 |
| ENSE00000807291 | 61536493 | 61536629 |
| ENSE00000807292 | 61539024 | 61539145 |
| ENSE00000807293 | 61545027 | 61545144 |
| ENSE00001011742 | 61549978 | 61550229 |
| ENSE00001383294 | 61554190 | 61555779 |
| ENSE00001609019 | 61500383 | 61500502 |
| ENSE00002227564 | 61333430 | 61333827 |
| ENSE00002284397 | 61490402 | 61490799 |
Expression profiles
Bgee: expression breadth ubiquitous, 148 present calls, max score 86.16.
FANTOM5 (CAGE): breadth broad, TPM avg 1.6073 / max 77.8897, expressed in 230 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 170493 | 1.1062 | 189 |
| 170495 | 0.2946 | 104 |
| 170494 | 0.1173 | 64 |
| 170496 | 0.0892 | 62 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 86.16 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 85.25 | gold quality |
| amygdala | UBERON:0001876 | 83.07 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 82.53 | gold quality |
| caudate nucleus | UBERON:0001873 | 82.46 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 82.20 | gold quality |
| putamen | UBERON:0001874 | 82.13 | gold quality |
| right frontal lobe | UBERON:0002810 | 81.45 | gold quality |
| nucleus accumbens | UBERON:0001882 | 81.41 | gold quality |
| spinal cord | UBERON:0002240 | 81.21 | gold quality |
| prefrontal cortex | UBERON:0000451 | 80.57 | gold quality |
| ganglionic eminence | UBERON:0004023 | 79.66 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.64 | gold quality |
| hypothalamus | UBERON:0001898 | 78.49 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 75.61 | gold quality |
| adrenal tissue | UBERON:0018303 | 75.23 | gold quality |
| substantia nigra | UBERON:0002038 | 74.90 | gold quality |
| neocortex | UBERON:0001950 | 74.73 | gold quality |
| frontal cortex | UBERON:0001870 | 73.73 | gold quality |
| medial globus pallidus | UBERON:0002477 | 73.46 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 73.11 | gold quality |
| forebrain | UBERON:0001890 | 72.31 | gold quality |
| brain | UBERON:0000955 | 71.44 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 71.07 | gold quality |
| cerebellar cortex | UBERON:0002129 | 71.04 | gold quality |
| cerebral cortex | UBERON:0000956 | 70.99 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 70.91 | gold quality |
| midbrain | UBERON:0001891 | 70.77 | gold quality |
| gastrocnemius | UBERON:0001388 | 70.58 | gold quality |
| corpus callosum | UBERON:0002336 | 69.48 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-35 | yes | 76.94 |
| E-HCAD-25 | yes | 24.12 |
| E-ANND-3 | yes | 5.37 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): E2F1
miRNA regulators (miRDB)
109 targeting CDH20, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-126-5P | 100.00 | 72.71 | 3180 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-4666A-3P | 99.96 | 71.71 | 3434 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-96-5P | 99.95 | 72.80 | 2140 |
| HSA-MIR-1236-3P | 99.94 | 68.04 | 1695 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Cdh20 | ENSMUSG00000050840 |
| rattus_norvegicus | Cdh20 | ENSRNOG00000014556 |
Paralogs (33): CDH1 (ENSG00000039068), CDH10 (ENSG00000040731), CDH3 (ENSG00000062038), CDH19 (ENSG00000071991), CDHR2 (ENSG00000074276), CDH17 (ENSG00000079112), CDH7 (ENSG00000081138), PCDH11Y (ENSG00000099715), CDHR5 (ENSG00000099834), PCDH11X (ENSG00000102290), CDH23 (ENSG00000107736), CDH9 (ENSG00000113100), CDH6 (ENSG00000113361), CDH26 (ENSG00000124215), CDHR3 (ENSG00000128536), CDH15 (ENSG00000129910), CDH24 (ENSG00000139880), CDH11 (ENSG00000140937), CDH13 (ENSG00000140945), CDH18 (ENSG00000145526), CDHR1 (ENSG00000148600), CDH22 (ENSG00000149654), CDH8 (ENSG00000150394), CDH12 (ENSG00000154162), PCDH1 (ENSG00000156453), DCHS1 (ENSG00000166341), PCDH7 (ENSG00000169851), CDH2 (ENSG00000170558), CDH4 (ENSG00000179242), CDH5 (ENSG00000179776), PCDH9 (ENSG00000184226), DCHS2 (ENSG00000197410), PCDH20 (ENSG00000280165)
Protein
Protein identifiers
Cadherin-20 — Q9HBT6 (reviewed: Q9HBT6)
All UniProt accessions (1): Q9HBT6
UniProt curated annotations — full annotation on UniProt →
Function. Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types.
Subcellular location. Cell membrane.
Tissue specificity. Expressed in placenta, adult brain, and fetal brain.
Domain organisation. Three calcium ions are usually bound at the interface of each cadherin domain and rigidify the connections, imparting a strong curvature to the full-length ectodomain.
RefSeq proteins (1): NP_114097* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000233 | Cadherin_Y-type_LIR | Domain |
| IPR002126 | Cadherin-like_dom | Domain |
| IPR015919 | Cadherin-like_sf | Homologous_superfamily |
| IPR020894 | Cadherin_CS | Conserved_site |
| IPR027397 | Catenin-bd_sf | Homologous_superfamily |
| IPR039808 | Cadherin | Family |
Pfam: PF00028, PF01049
UniProt features (26 total): sequence variant 6, domain 5, sequence conflict 5, glycosylation site 4, topological domain 2, signal peptide 1, propeptide 1, chain 1, transmembrane region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9HBT6-F1 | 77.33 | 0.46 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (4): 261, 420, 461, 542
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 206 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP, BENPORATH_ES_WITH_H3K27ME3, GU_PDEF_TARGETS_DN, TGACCTY_ERR1_Q2, CHX10_01, GOBP_CALCIUM_DEPENDENT_CELL_CELL_ADHESION, REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS, GOBP_CELL_CELL_ADHESION, GOBP_CELL_JUNCTION_ORGANIZATION, AACTTT_UNKNOWN, MYB_Q3, chr18q22, HNF1_C, GOBP_CELL_JUNCTION_ASSEMBLY, GOBP_ADHERENS_JUNCTION_ORGANIZATION
GO Biological Process (9): cell morphogenesis (GO:0000902), cell-cell junction assembly (GO:0007043), homophilic cell-cell adhesion (GO:0007156), calcium-dependent cell-cell adhesion (GO:0016339), cell migration (GO:0016477), adherens junction organization (GO:0034332), cell-cell adhesion mediated by cadherin (GO:0044331), cell adhesion (GO:0007155), cell-cell adhesion (GO:0098609)
GO Molecular Function (4): calcium ion binding (GO:0005509), beta-catenin binding (GO:0008013), cadherin binding (GO:0045296), metal ion binding (GO:0046872)
GO Cellular Component (4): adherens junction (GO:0005912), catenin complex (GO:0016342), plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell-cell adhesion | 3 |
| cell-cell junction organization | 2 |
| anatomical structure morphogenesis | 1 |
| cell junction assembly | 1 |
| cell motility | 1 |
| cellular process | 1 |
| cell adhesion | 1 |
| metal ion binding | 1 |
| protein binding | 1 |
| cell adhesion molecule binding | 1 |
| cation binding | 1 |
| cell-cell junction | 1 |
| extrinsic component of plasma membrane | 1 |
| plasma membrane protein complex | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1134 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| CDH20 | CDH15 | P55291 | 659 |
| CDH20 | CDH2 | P19022 | 637 |
| CDH20 | CDH10 | Q9Y6N8 | 626 |
| CDH20 | CDH6 | P55285 | 571 |
| CDH20 | SMARCA4 | P51532 | 511 |
| CDH20 | CDH4 | P55283 | 507 |
| CDH20 | CTNNB1 | P35222 | 464 |
| CDH20 | CDH3 | P22223 | 452 |
| CDH20 | CDH8 | P55286 | 451 |
| CDH20 | CDH12 | P55289 | 446 |
| CDH20 | CDH9 | Q9ULB4 | 417 |
| CDH20 | CDH18 | Q13634 | 413 |
| CDH20 | CDH11 | P55287 | 407 |
| CDH20 | RNF152 | Q8N8N0 | 396 |
| CDH20 | ABT1 | Q9ULW3 | 396 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FMR1 | CDH20 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (3): CDH20 (Affinity Capture-MS), CDH20 (Biochemical Activity), CDH20 (Protein-peptide)
ESM2 similar proteins: A0A8M2BIB6, F1QSQ0, F8W3X3, H2EQR6, O35902, O54800, O55111, O93319, P32926, P33545, P55280, P55285, P55286, P55287, P55288, P55289, P55292, P55849, P55850, P70407, P70408, P79995, P97291, P97326, Q01107, Q02413, Q02487, Q08554, Q08DJ5, Q13634, Q14126, Q14574, Q28060, Q3SWX5, Q5DWV1, Q5RJH3, Q61495, Q68SP4, Q6W3B0, Q7TMD7
Diamond homologs: A0A8M2BIB6, B0KW95, B2KI42, B4USZ0, F1PAA9, F1QSQ0, O02840, O35902, O54800, O55075, O55111, O93319, P08641, P09803, P10287, P10288, P12830, P15116, P19022, P19534, P19535, P20310, P22223, P24503, P30944, P32926, P33145, P33146, P33147, P33148, P33150, P33151, P33152, P33545, P39038, P55280, P55283, P55284, P55285, P55286
SIGNOR signaling
2 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| calcium(2+) | “up-regulates activity” | CDH20 | “chemical activation” |
| CDH20 | “up-regulates activity” | CTNNB1 | binding |
Disease & clinical
Clinical variants and AI predictions
ClinVar
118 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 110 |
| Likely benign | 3 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2730 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 18:61500377:CCCCA:C | acceptor_loss | 1.0000 |
| 18:61500378:CCCAG:C | acceptor_loss | 1.0000 |
| 18:61500379:CCAGG:C | acceptor_loss | 1.0000 |
| 18:61500380:CA:C | acceptor_loss | 1.0000 |
| 18:61500381:A:AC | acceptor_loss | 1.0000 |
| 18:61500449:T:TA | donor_gain | 1.0000 |
| 18:61500450:G:GA | donor_gain | 1.0000 |
| 18:61500499:ACAG:A | donor_loss | 1.0000 |
| 18:61500501:AGGT:A | donor_loss | 1.0000 |
| 18:61500502:GG:G | donor_loss | 1.0000 |
| 18:61503119:GA:G | donor_gain | 1.0000 |
| 18:61536628:GA:G | donor_gain | 1.0000 |
| 18:61536630:G:GG | donor_gain | 1.0000 |
| 18:61539022:A:AG | acceptor_gain | 1.0000 |
| 18:61539023:G:GG | acceptor_gain | 1.0000 |
| 18:61539023:GAC:G | acceptor_gain | 1.0000 |
| 18:61539023:GACA:G | acceptor_gain | 1.0000 |
| 18:61539142:ACAG:A | donor_loss | 1.0000 |
| 18:61539143:CAG:C | donor_loss | 1.0000 |
| 18:61539144:AG:A | donor_loss | 1.0000 |
| 18:61539145:GG:G | donor_loss | 1.0000 |
| 18:61539146:G:GT | donor_loss | 1.0000 |
| 18:61539147:T:TC | donor_loss | 1.0000 |
| 18:61550230:G:GC | donor_loss | 1.0000 |
| 18:61550231:T:G | donor_loss | 1.0000 |
| 18:61554184:T:A | acceptor_gain | 1.0000 |
| 18:61333822:TGCC:T | donor_gain | 0.9900 |
| 18:61333825:CAGGT:C | donor_loss | 0.9900 |
| 18:61333826:AGGTA:A | donor_loss | 0.9900 |
| 18:61333828:G:GC | donor_loss | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000001072 (18:61359640 A>G), RS1000006175 (18:61355076 G>A), RS1000014985 (18:61527226 T>C), RS1000028495 (18:61533656 T>C), RS1000040628 (18:61476700 A>G), RS1000049353 (18:61399079 G>A), RS1000065179 (18:61343649 C>G,T), RS1000068948 (18:61398644 C>G), RS1000069512 (18:61358921 C>T), RS1000072670 (18:61483349 T>C), RS1000087201 (18:61520924 G>A,C), RS1000104667 (18:61483924 T>A), RS1000119286 (18:61397684 A>C), RS1000121578 (18:61358548 C>T), RS1000152756 (18:61405734 G>A)
Disease associations
OMIM: gene MIM:605807 | disease phenotypes:
GenCC curated gene-disease
Mondo (1): non-syndromic syndactyly (MONDO:0019530)
Orphanet (1): Non-syndromic syndactyly (Orphanet:90025)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
5 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_750 | Obesity-related traits | 6.000000e-06 |
| GCST002930_15 | Cobalt levels | 7.000000e-06 |
| GCST004370_9 | Deep ovarian and/or rectovaginal disease with dense adhesions | 1.000000e-06 |
| GCST007094_69 | Diastolic blood pressure | 1.000000e-08 |
| GCST007482_1 | Handedness | 4.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0003939 | energy intake |
| EFO:0006336 | diastolic blood pressure |
| EFO:0009902 | handedness |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
14 total (human), top 14 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Aflatoxin B1 | decreases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol A | affects methylation, decreases methylation, affects cotreatment | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| benzo(e)pyrene | decreases methylation | 1 |
| ferrous chloride | decreases expression | 1 |
| tetrachlorodian | decreases expression | 1 |
| Fulvestrant | affects cotreatment, affects methylation | 1 |
| Acetaminophen | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Methapyrilene | decreases methylation | 1 |
| Triclosan | decreases expression | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
Clinical trials (associated diseases)
4 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT04564430 | PHASE4 | UNKNOWN | Clonidine for Tourniquet-related Pain in Children |
| NCT03107546 | Not specified | COMPLETED | Comparison of Scar Formation in Syndactyly Release Surgery With Full Thickness Skin Graft Versus Skin Graft Substitute |
| NCT06239064 | Not specified | ACTIVE_NOT_RECRUITING | Early Genetic Identification of Obesity |
| NCT07596862 | Not specified | COMPLETED | Remote Assesment of Functional Sequelae in Patients Operated for Congenital Syndactyly |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): endometriosis, non-syndromic syndactyly